IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

World Zoonoses Day 2024: IAVI celebrates progress in Lassa vaccine development

July 5, 2024

A series of publications highlights advancements in countermeasures for Lassa fever, an animal-borne illness

Read more

Press Releases

Advancing toward a preventative HIV vaccine

July 2, 2024

Across four preclinical studies, Scripps Research, IAVI, and additional collaborators make headway in stimulating the rare antibodies needed to fight HIV.

Read more

Scientific Publications

Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries

Read more

Podcasts

Meet The Scientist Episode 3: Dr. Elana Van Brakel on IAVI’s TB vaccine program

June 26, 2024

In the latest episode of Meet the Scientist, IAVI’s podcast series, we sat down with Elana Van Brakel, medical director at IAVI in Cape Town, South Africa, to discuss her work at IAVI in support of our TB vaccine program. In this episode, we explore IAVI’s diverse engagement in the development of the MTBVAC TB vaccine candidate and learn about how Elana and IAVI’s TB team are preparing for the Phase 2b clinical trial of MTBVAC in adolescents and adults in sub-Saharan Africa. Tune in to learn more about Elana’s work and IAVI’s TB vaccine program.

Read more

Features

Meet The Scientist podcast: An interview with Dr. Elana Van Brakel, Medical Director at IAVI, on IAVI’s TB vaccine program

June 26, 2024

In this episode of Meet the Scientist, we explore IAVI’s efforts in the late-stage development of the MTBVAC TB vaccine candidate

Read more

Features

Advocates push for local manufacturing to achieve health equity in Africa 

June 24, 2024

Research literacy learning collaborative led by CASPR brings together health advocates in Africa, linking the science of vaccine development to vaccine advocacy.

Read more

IAVI Report

Building better B cells: An interview with James Voss

June 18, 2024

Voss and his team are using gene editing technologies to reprogram B cells to make broadly neutralizing antibodies against HIV. Will this be a route to a functional cure?

Read more

Features

Don’t miss out on the 7th Global Forum on TB Vaccines this October

June 18, 2024

IAVI is honored to be co-organizing the 7th Global Forum on TB Vaccines at a time of heightened attention to TB vaccine development and implementation.

Read more